user

Real-World Clinical Characteristics of COVID-19 Patients With or Without Evidence of Allergic Asthma

被引：0
|
作者：
Kaner, R. J. [1 ]
Murphy, T. R. [2 ]
Holweg, C. [3 ]
Rajput, Y. [4 ]
Raimundo, K. [4 ]
Seetasith, A. [4 ]
Meyer, C. S. [4 ]
Iqbal, A. [5 ]
Busse, W. [6 ]
机构：
[1] Weill Cornell Med Coll Cornell, New York, NY USA
[2] Charleston ENT & Allergy, Charleston, SC USA
[3] South San Francisco, San Francisco, CA USA
[4] Genentech Inc, San Francisco, CA USA
[5] US Med Affairs, Genentech, San Francisco, CA USA
[6] Univ Wisconsin Hosp, Med, Madison, WI USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1275
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Validation of real-world case definitions for COVID-19 diagnosis and severe COVID-19 illness among patients infected with SARS-CoV-2: Translation of clinical trial definitions to real-world settings
    Duh, Mei Sheng
    Nguyen, Catherine
    Rubino, Heather
    Herrick, Christopher
    Chang, Rose
    DerSarkissian, Maral
    Hsieh, Yichuan Grace
    Banatwala, Azeem
    Yu, Louise H.
    Belsky, Gregory
    Boyle-Kelly, Janet
    Cagan, Andrew
    Stangle, Bruce E.
    Cremieux, Pierre Y.
    Kolitsopoulos, Francesca
    Murphy, Shawn N.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 281 - 281
  • [42] Real-World Observational Study on the Characteristics and Treatment Patterns of Allergic Asthma Patients Receiving Omalizumab in Canada
    Lee, Jason K.
    Amin, Suvina
    Erdmann, Michelle
    Kukaswadia, Atif
    Ivanovic, Jelena
    Fischer, Aren
    Gendron, Alain
    PATIENT PREFERENCE AND ADHERENCE, 2020, 14 : 725 - 735
  • [43] Effectiveness and Safety of Enoxaparin Versus Unfractionated Heparin as Thromboprophylaxis in Hospitalized COVID-19 Patients: Real-World Evidence
    AlLehaibi, Lina H.
    Alomar, Mukhtar
    Almulhim, Abdulaziz
    Al-Makki, Sarah
    Alrwaili, Nazar R.
    Al-Bassam, Shahad
    Alsultan, Semat
    Al Saeed, Jenan
    Alsheef, Mohammad
    Abraham, Ivo
    Alamer, Ahmad
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (04) : 361 - 374
  • [44] Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients
    Cameron Mura
    Saskia Preissner
    Susanne Nahles
    Max Heiland
    Philip E. Bourne
    Robert Preissner
    Signal Transduction and Targeted Therapy, 6
  • [45] Real-world evidence of remdesivir in formerly hospitalized COVID-19 patients: patient-reported and functional outcomes
    Fesue, Dorottya
    Barczi, Eniko
    Csoma, Balazs
    Polivka, Lorinc
    Boga, Marton
    Horvath, Gabor
    Varga, Janos Tamas
    Sebok, Szilvia
    Mueller, Veronika
    BMC INFECTIOUS DISEASES, 2025, 25 (01)
  • [46] Burden of diabetes mellitus and its impact on COVID-19 patients: A meta-analysis of real-world evidence
    Hussain, Salman
    Baxi, Harveen
    Jamali, Mohammad Chand
    Nisar, Nazima
    Hussain, Md Sarfaraj
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (06) : 1595 - 1602
  • [47] Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients
    Mura, Cameron
    Preissner, Saskia
    Nahles, Susanne
    Heiland, Max
    Bourne, Philip E.
    Preissner, Robert
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [48] Variability in the Clinical Course of COVID-19 in a Retrospective Analysis of a Large Real-World Database
    Flisiak, Robert
    Rzymski, Piotr
    Zarebska-Michaluk, Dorota
    Ciechanowski, Przemyslaw
    Dobrowolska, Krystyna
    Rogalska, Magdalena
    Jaroszewicz, Jerzy
    Szymanek-Pasternak, Anna
    Rorat, Marta
    Kozielewicz, Dorota
    Kowalska, Justyna
    Dutkiewicz, Ewa
    Sikorska, Katarzyna
    Moniuszko-Malinowska, Anna
    VIRUSES-BASEL, 2023, 15 (01):
  • [49] Tocilizumab effectiveness in mechanically ventilated COVID-19 patients (T-MVC-19 Study): a multicenter real-world evidence
    Mohzari, Yahya A.
    Alamer, Ahmad
    Alattas, Majda
    Alrashed, Ahmed A.
    Alshehab, Nura A.
    Alkhaldi, Turkiah K.
    Alamer, Amnah A.
    Asdaq, Syed M. B.
    Aljefri, Doaa
    Alajami, Hamdan N.
    Alsowaida, Yazed S.
    Mathew, Maya
    AlMusawa, Mohammed, I
    Alomar, Mukhtar
    Alharbi, Raghad Y.
    Khuwaja, Malik
    Bamogaddam, Reem F.
    Alharthi, Ashwaq H.
    Faqihi, Aisha Y.
    Alrumayyan, Bashayer F.
    Alshareef, Abeer
    Alhassan, Batool M.
    Damfu, Nader Y.
    Alajmi, Ghada S.
    Albujaidy, Asma
    Alghalbi, Maram
    Alajlan, Saleh A.
    Abraham, Ivo
    Almulhim, Abdulaziz S.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (07) : 1037 - 1047
  • [50] Real-world evidence and biomarkers in allergic diseases
    Shamji, Mohamed H.
    Boyle, Robert J.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (04): : 238 - 240
12345